1071449-08-5 Usage
General Description
(7-Bromoindan-1-yl)amine is a chemical compound with the molecular formula C9H10BrN. It is an amine derivative of 7-bromoindane, which is a bicyclic aromatic compound. This chemical has potential applications in the pharmaceutical industry, particularly in the development of new drugs and compounds. It is also used in research and development of various organic and medicinal compounds. The compound's structure and properties make it suitable for use in organic synthesis and as a building block for the synthesis of more complex molecules. However, it is important to handle and use this compound with care due to its potential hazards and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 1071449-08-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,1,4,4 and 9 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1071449-08:
(9*1)+(8*0)+(7*7)+(6*1)+(5*4)+(4*4)+(3*9)+(2*0)+(1*8)=135
135 % 10 = 5
So 1071449-08-5 is a valid CAS Registry Number.
1071449-08-5Relevant articles and documents
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
-
Paragraph 0361; 0362; 0400, (2015/02/18)
The invention relates to heterocyclic amide derivatives of formula (I), wherein R1, R2, R3, X and n are as defined in the description, their preparation and their use as pharmaceutically active compounds.
Rigid analogues of antimitotic indolobenzazepinones: New insights into tubulin binding via molecular modeling
Pons, Valerie,Beaumont, Stephane,Tran Huu Dau, Marie Elise,Iorga, Bogdan I.,Dodd, Robert H.
experimental part, p. 565 - 570 (2011/10/02)
Two rigid analogues of 5-ethylindolobenzazepinone 4, a potent cytotoxic agent and inhibitor of tubulin polymerization, were prepared. The first was the indane derivative 5, in which the ethyl group is attached to the benzo moiety. The second was the pyrro
SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS
-
Page/Page column 23, (2008/12/04)
Therapeutic compounds, and methods, compositions, and medicaments related thereto are disclosed herein.